Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease
T Athar, K Al Balushi, SA Khan - Molecular biology reports, 2021 - Springer
Alzheimer's disease (AD) is a neurodegenerative old age disease that is complex,
multifactorial, unalterable, and progressive in nature. The currently approved therapy …
multifactorial, unalterable, and progressive in nature. The currently approved therapy …
Alzheimer's disease, dementia, and stem cell therapy
T Duncan, M Valenzuela - Stem cell research & therapy, 2017 - Springer
Alzheimer's disease (AD) represents arguably the most significant social, economic, and
medical crisis of our time. Characterized by progressive neurodegenerative pathology, AD is …
medical crisis of our time. Characterized by progressive neurodegenerative pathology, AD is …
In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model
Loss of neurons after brain injury and in neurodegenerative disease is often accompanied
by reactive gliosis and scarring, which are difficult to reverse with existing treatment …
by reactive gliosis and scarring, which are difficult to reverse with existing treatment …
Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model
P Rivetti Di Val Cervo, RA Romanov, G Spigolon… - Nature …, 2017 - nature.com
Cell replacement therapies for neurodegenerative disease have focused on transplantation
of the cell types affected by the pathological process. Here we describe an alternative …
of the cell types affected by the pathological process. Here we describe an alternative …
Direct lineage reprogramming: strategies, mechanisms, and applications
J Xu, Y Du, H Deng - Cell stem cell, 2015 - cell.com
The direct lineage reprogramming of one specialized cell type into another using defined
factors has fundamentally re-shaped traditional concepts regarding the epigenetic stability of …
factors has fundamentally re-shaped traditional concepts regarding the epigenetic stability of …
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience
The scarcity of live human brain cells for experimental access has for a long time limited our
ability to study complex human neurological disorders and elucidate basic neuroscientific …
ability to study complex human neurological disorders and elucidate basic neuroscientific …
[HTML][HTML] Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation
Directed neuronal differentiation of human pluripotent stem cells (hPSCs), neural
progenitors, or fibroblasts using transcription factors has allowed for the rapid and highly …
progenitors, or fibroblasts using transcription factors has allowed for the rapid and highly …
How to make a midbrain dopaminergic neuron
Midbrain dopaminergic (mDA) neuron development has been an intense area of research
during recent years. This is due in part to a growing interest in regenerative medicine and …
during recent years. This is due in part to a growing interest in regenerative medicine and …
Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons
ML Liu, T Zang, Y Zou, JC Chang, JR Gibson… - Nature …, 2013 - nature.com
Cell fate can be reprogrammed by modifying intrinsic and extrinsic cues. Here we show that
two small molecules (forskolin and dorsomorphin) enable the transcription factor …
two small molecules (forskolin and dorsomorphin) enable the transcription factor …
Neural stem cell‐based treatment for neurodegenerative diseases
Human neurodegenrative diseases such as P arkinson's disease (PD), H untington's
disease (HD), amyotrophic lateral sclerosis (ALS) and A lzheimer's disease (AD) are caused …
disease (HD), amyotrophic lateral sclerosis (ALS) and A lzheimer's disease (AD) are caused …